USS Investment Management Ltd Has $6.75 Million Stock Holdings in Waters Corporation $WAT

USS Investment Management Ltd grew its stake in shares of Waters Corporation (NYSE:WAT) by 12.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,657 shares of the medical instruments supplier’s stock after purchasing an additional 2,420 shares during the period. USS Investment Management Ltd’s holdings in Waters were worth $6,749,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Zions Bancorporation National Association UT boosted its holdings in shares of Waters by 121.2% in the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 40 shares during the period. SHP Wealth Management acquired a new stake in shares of Waters during the fourth quarter valued at approximately $32,000. DV Equities LLC purchased a new stake in shares of Waters in the 4th quarter valued at approximately $32,000. Louisbourg Investments Inc. purchased a new stake in shares of Waters in the 1st quarter valued at approximately $30,000. Finally, North Star Investment Management Corp. boosted its stake in Waters by 10,200.0% in the 1st quarter. North Star Investment Management Corp. now owns 103 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 102 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Up 0.1%

Waters stock opened at $378.62 on Friday. The firm has a market cap of $37.18 billion, a PE ratio of 48.11, a P/E/G ratio of 2.29 and a beta of 1.20. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.13 and a current ratio of 1.79. The firm’s 50 day moving average price is $350.65 and its two-hundred day moving average price is $346.80. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15.

Waters (NYSE:WAT) last released its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. During the same quarter in the prior year, the firm earned $2.25 EPS. The company’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, research analysts predict that Waters Corporation will post 14.51 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Waters from $330.00 to $345.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Bank of America increased their target price on Waters from $370.00 to $400.00 and gave the company a “neutral” rating in a report on Tuesday, June 2nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a research report on Monday, April 20th. Piper Sandler initiated coverage on Waters in a report on Thursday, June 11th. They set a “neutral” rating and a $400.00 price target on the stock. Finally, HSBC upped their price target on Waters from $415.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, June 3rd. Four analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $396.68.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.